Neoadjuvant HER2+


The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

Latest News

Aiham Qdaisat, MD, of MD Anderson Cancer Center
Breast-Conserving Therapy Bests Mastectomy After Preoperative Systemic Therapy in HER2+ Breast Cancer

April 9th 2024

Following preoperative systemic therapy, breast-conserving therapy led to superior OS vs mastectomy in HER2-positive breast cancer.

Shruti Tiwari, MD, medical oncologist, Virginia Cancer Specialists
Tiwari Highlights Updates in HER2+ and HER2-Low Breast Cancer

April 4th 2024

Debu Tripathy, MD, of The University of Texas MD Anderson Cancer Center
Tripathy Outlines Where the HER2+ Early-Stage Breast Cancer Landscape Stands

April 3rd 2024

Debu Tripathy, MD
HER2-Directed Therapies Continue to Shape Improved Breast Cancer Outcomes

March 10th 2024

HER2-Positive Breast Cancer
T-DXd Has Intracranial Activity in Meta-Analysis of HER2+ Breast Cancer Brain Metastases

March 8th 2024

Video Series
Video Interviews
Tripathy Spotlights the State of Treatment in Metastatic HER2+ Breast Cancer

More News